Company:  AMGEN INC (AMGN)
Form Type:  10-K
Filing Date:  2/29/2012 
CIK:  0000318154 
Address:  ONE AMGEN CENTER DRIVE 
City, State, Zip:  THOUSAND OAKS, California 91320 
Telephone:  (805)447-1000 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$113.72  
Change: 
0.405 (0.36%)  
Trade Time: 
Apr 24  
Market Cap: 
$86.09B
Description of Business
Amgen Inc. (including its subsidiaries, referred to as �Amgen,� �the Company,� �we,� �our� or �us�) is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer, Amgen has grown to be the world's largest independent biotechnology company, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. We were incorporated in California in 1980 and became a Delaware corporation in 1987.
Register for EDGAR Pro and access this filing in:     
  FORM 10-K
    PART I
      Item 1. BUSINESS
      Item 1A. RISK FACTORS
      Item 1B. UNRESOLVED STAFF COMMENTS
      Item 2. PROPERTIES
      Item 3. LEGAL PROCEEDINGS
      Item 4. MINE SAFETY DISCLOSURES
    PART II
      Item 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED ...
      Item 6. SELECTED FINANCIAL DATA
      Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
        Results of Operations
        Financial Condition, Liquidity and Capital Resources
      Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT ...
      Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
      Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ...
      Item 9A. CONTROLS AND PROCEDURES
      Report of Independent Registered Public Accounting Firm
      Item 9B. OTHER INFORMATION
    PART III
      Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE ...
      Item 11. EXECUTIVE COMPENSATION
      Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND ...
      Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND ...
      Item 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
    PART IV
      Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
    SIGNATURES
    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
    Report of Independent Registered Public Accounting Firm
    INCOME STATEMENT
    BALANCE SHEET
    BALANCE SHEET
    STOCKHOLDERS EQUITY
    CASH FLOW
    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
      BALANCE SHEET
      CASH FLOW
      BALANCE SHEET
  EXHIBIT 10.10
  EXHIBIT 10.11
  EXHIBIT 10.18
  EXHIBIT 10.21
  EXHIBIT 10.52
  EXHIBIT 21
    SUBSIDIARIES
  EXHIBIT 31
    CERTIFICATIONS
  EXHIBIT 32
    Certification of Chief Executive Officer
BROKERAGE PARTNERS